Progyny Past Earnings Performance
Past criteria checks 5/6
Progyny has been growing earnings at an average annual rate of 36%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 37.2% per year. Progyny's return on equity is 10.7%, and it has net margins of 5.5%.
Key information
36.0%
Earnings growth rate
42.0%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 37.2% |
Return on equity | 10.7% |
Net Margin | 5.5% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Progyny: Recent Stock Decline Provides Buying Opportunity
Jul 12Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall
Jun 23Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore
Jun 10Progyny: No Change To Long-Term Outlook
Jun 04Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price
Apr 29Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?
Apr 03Progyny: Long-Term Outlook Remains Positive, Reiterate Buy
Mar 15Progyny: Long-Term Thesis Still Intact
Mar 09Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher
Mar 01Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable
Jan 07Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?
Dec 11Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)
Nov 08Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?
Aug 24There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital
Aug 06Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital
May 06When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?
Jan 25Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue
Dec 12Is It Time To Consider Buying Progyny, Inc. (NASDAQ:PGNY)?
Oct 18Progyny Stock Should Deliver Superior Returns For Investors
Aug 05Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)
Jul 27At US$31.63, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?
Jul 08Progyny: Solving Infertility Problem
Jul 05Progyny Stock: A Hidden Gem Tackling Infertility
May 31Revenue & Expenses Breakdown
How Progyny makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 1,108 | 61 | 177 | 0 |
31 Dec 23 | 1,089 | 62 | 177 | 0 |
30 Sep 23 | 1,033 | 52 | 175 | 0 |
30 Jun 23 | 957 | 49 | 165 | 0 |
31 Mar 23 | 873 | 43 | 155 | 0 |
31 Dec 22 | 787 | 30 | 144 | 0 |
30 Sep 22 | 700 | 42 | 128 | 0 |
30 Jun 22 | 617 | 46 | 113 | 0 |
31 Mar 22 | 551 | 56 | 96 | 0 |
31 Dec 21 | 501 | 66 | 80 | 0 |
30 Sep 21 | 473 | 90 | 68 | 0 |
30 Jun 21 | 450 | 78 | 61 | 0 |
31 Mar 21 | 386 | 58 | 56 | 0 |
31 Dec 20 | 345 | 46 | 62 | 0 |
30 Sep 20 | 310 | 3 | 49 | 0 |
30 Jun 20 | 272 | -10 | 45 | 0 |
31 Mar 20 | 264 | -5 | 41 | 0 |
31 Dec 19 | 230 | -9 | 36 | 0 |
30 Sep 19 | 194 | -6 | 30 | 0 |
30 Jun 19 | 160 | 1 | 27 | 0 |
31 Mar 19 | 130 | -4 | 24 | 0 |
31 Dec 18 | 105 | -6 | 23 | 0 |
31 Dec 17 | 49 | -13 | 18 | 0 |
Quality Earnings: PGNY has high quality earnings.
Growing Profit Margin: PGNY's current net profit margins (5.5%) are higher than last year (4.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PGNY has become profitable over the past 5 years, growing earnings by 36% per year.
Accelerating Growth: PGNY's earnings growth over the past year (42.2%) exceeds its 5-year average (36% per year).
Earnings vs Industry: PGNY earnings growth over the past year (42.2%) exceeded the Healthcare industry 14.9%.
Return on Equity
High ROE: PGNY's Return on Equity (10.7%) is considered low.